Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids.
|
N Engl J Med
|
2010
|
6.51
|
2
|
Long-term inhaled corticosteroids in preschool children at high risk for asthma.
|
N Engl J Med
|
2006
|
6.10
|
3
|
Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.
|
N Engl J Med
|
2011
|
5.61
|
4
|
Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial.
|
Lancet
|
2011
|
5.42
|
5
|
Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
|
J Allergy Clin Immunol
|
2005
|
4.50
|
6
|
Daily or intermittent budesonide in preschool children with recurrent wheezing.
|
N Engl J Med
|
2011
|
4.09
|
7
|
Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial.
|
Lancet
|
2008
|
4.06
|
8
|
Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.
|
J Pediatr
|
2007
|
3.49
|
9
|
Tucson Children's Respiratory Study: 1980 to present.
|
J Allergy Clin Immunol
|
2003
|
3.41
|
10
|
Inner City Asthma Study: relationships among sensitivity, allergen exposure, and asthma morbidity.
|
J Allergy Clin Immunol
|
2005
|
3.38
|
11
|
Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study.
|
Lancet
|
2007
|
3.22
|
12
|
Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma.
|
J Allergy Clin Immunol
|
2004
|
2.80
|
13
|
Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
|
J Allergy Clin Immunol
|
2006
|
2.79
|
14
|
Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study.
|
Lancet
|
2008
|
2.70
|
15
|
Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing.
|
J Allergy Clin Immunol
|
2008
|
2.56
|
16
|
Cost-effectiveness of a home-based environmental intervention for inner-city children with asthma.
|
J Allergy Clin Immunol
|
2005
|
2.22
|
17
|
Clinical screening of school children for polysomnography to detect sleep-disordered breathing--the Tucson Children's Assessment of Sleep Apnea study (TuCASA).
|
J Clin Sleep Med
|
2005
|
2.21
|
18
|
Persistence of asthma symptoms during adolescence: role of obesity and age at the onset of puberty.
|
Am J Respir Crit Care Med
|
2004
|
2.20
|
19
|
Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.
|
J Allergy Clin Immunol
|
2006
|
2.02
|
20
|
Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis.
|
J Pediatr
|
2003
|
1.97
|
21
|
The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education network.
|
Control Clin Trials
|
2004
|
1.79
|
22
|
Pulmonary outcome prediction (POP) tools for cystic fibrosis patients.
|
Pediatr Pulmonol
|
2010
|
1.71
|
23
|
Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.
|
Pediatr Pulmonol
|
2007
|
1.67
|
24
|
Asthma control, adiposity, and adipokines among inner-city adolescents.
|
J Allergy Clin Immunol
|
2010
|
1.63
|
25
|
Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis.
|
J Pediatr
|
2008
|
1.60
|
26
|
Effect of breastfeeding on lung function in childhood and modulation by maternal asthma and atopy.
|
Am J Respir Crit Care Med
|
2007
|
1.59
|
27
|
Risk of current asthma among adult smokers with respiratory syncytial virus illnesses in early life.
|
Am J Respir Crit Care Med
|
2014
|
1.54
|
28
|
Clinical outcomes associated with sleep-disordered breathing in Caucasian and Hispanic children--the Tucson Children's Assessment of Sleep Apnea study (TuCASA).
|
Sleep
|
2003
|
1.48
|
29
|
Learning in children and sleep disordered breathing: findings of the Tucson Children's Assessment of Sleep Apnea (tuCASA) prospective cohort study.
|
J Int Neuropsychol Soc
|
2003
|
1.27
|
30
|
Symptoms related to sleep-disordered breathing in white and Hispanic children: the Tucson Children's Assessment of Sleep Apnea Study.
|
Chest
|
2003
|
1.24
|
31
|
Airborne fungi in the homes of children with asthma in low-income urban communities: The Inner-City Asthma Study.
|
J Allergy Clin Immunol
|
2004
|
1.24
|
32
|
Asthma outcomes workshop: overview.
|
J Allergy Clin Immunol
|
2012
|
1.22
|
33
|
Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma.
|
J Allergy Clin Immunol
|
2009
|
1.21
|
34
|
A randomized clinical trial of clinician feedback to improve quality of care for inner-city children with asthma.
|
Pediatrics
|
2006
|
1.12
|
35
|
Development and validation of the Composite Asthma Severity Index--an outcome measure for use in children and adolescents.
|
J Allergy Clin Immunol
|
2012
|
1.12
|
36
|
Lower airway obstruction is associated with increased morbidity in children with sickle cell disease.
|
Pediatr Pulmonol
|
2009
|
1.06
|
37
|
Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis.
|
Pediatr Pulmonol
|
2011
|
1.06
|
38
|
Behavior problems associated with sleep disordered breathing in school-aged children--the Tucson children's assessment of sleep apnea study.
|
J Pediatr Psychol
|
2005
|
1.02
|
39
|
Differential effects of outdoor versus indoor fungal spores on asthma morbidity in inner-city children.
|
J Allergy Clin Immunol
|
2010
|
1.01
|
40
|
Year-to-year changes in lung function in individuals with cystic fibrosis.
|
J Cyst Fibros
|
2010
|
1.00
|
41
|
Trends in the use of routine therapies in cystic fibrosis: 1995-2005.
|
Pediatr Pulmonol
|
2010
|
1.00
|
42
|
Lack of a relation between serum 25-hydroxyvitamin D concentrations and asthma in adolescents.
|
Am J Clin Nutr
|
2013
|
1.00
|
43
|
Socioeconomic status and the likelihood of antibiotic treatment for signs and symptoms of pulmonary exacerbation in children with cystic fibrosis.
|
J Pediatr
|
2011
|
0.99
|
44
|
Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study.
|
J Allergy Clin Immunol
|
2008
|
0.98
|
45
|
Impact of pregnancy on women with cystic fibrosis.
|
Chest
|
2006
|
0.97
|
46
|
Trends in the clinical characteristics of the U.S. cystic fibrosis patient population from 1995 to 2005.
|
Pediatr Pulmonol
|
2008
|
0.97
|
47
|
Risk factors for rate of decline in FEV1 in adults with cystic fibrosis.
|
J Cyst Fibros
|
2012
|
0.97
|
48
|
Sleep architecture in normal Caucasian and Hispanic children aged 6-11 years recorded during unattended home polysomnography: experience from the Tucson Children's Assessment of Sleep Apnea Study (TuCASA).
|
Sleep Med
|
2003
|
0.96
|
49
|
Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function.
|
Pediatrics
|
2007
|
0.95
|
50
|
Lung function decline from adolescence to young adulthood in cystic fibrosis.
|
Pediatr Pulmonol
|
2011
|
0.95
|
51
|
Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis.
|
Pediatr Pulmonol
|
2012
|
0.92
|
52
|
Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis.
|
J Cyst Fibros
|
2012
|
0.92
|
53
|
Long-term outcomes of early-onset wheeze and asthma.
|
J Allergy Clin Immunol
|
2012
|
0.90
|
54
|
Parasomnias and sleep disordered breathing in Caucasian and Hispanic children - the Tucson children's assessment of sleep apnea study.
|
BMC Med
|
2004
|
0.89
|
55
|
Comparison between reported and recorded total sleep time and sleep latency in 6- to 11-year-old children: the Tucson Children's Assessment of Sleep Apnea Study (TuCASA).
|
Sleep Breath
|
2007
|
0.89
|
56
|
Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms.
|
Pediatr Pulmonol
|
2012
|
0.88
|
57
|
Combined effects of parental and active smoking on early lung function deficits: a prospective study from birth to age 26 years.
|
Thorax
|
2013
|
0.87
|
58
|
Relationship between infant weight gain and later asthma.
|
Pediatr Allergy Immunol
|
2009
|
0.87
|
59
|
Changing thresholds and incidence of antibiotic treatment of cystic fibrosis pulmonary exacerbations, 1995-2005.
|
J Cyst Fibros
|
2012
|
0.86
|
60
|
Lymphoscintigraphy in plastic bronchitis, a pediatric case report.
|
Pediatr Pulmonol
|
2012
|
0.86
|
61
|
Genetic variation in vascular endothelial growth factor-a and lung function.
|
Am J Respir Crit Care Med
|
2012
|
0.86
|
62
|
Impaired lung diffusing capacity for nitric oxide and alveolar-capillary membrane conductance results in oxygen desaturation during exercise in patients with cystic fibrosis.
|
J Cyst Fibros
|
2010
|
0.85
|
63
|
Early childhood wheezing is associated with lower lung function in cystic fibrosis.
|
Pediatr Pulmonol
|
2013
|
0.83
|
64
|
Ventilatory drive and the apnea-hypopnea index in six-to-twelve year old children.
|
BMC Pulm Med
|
2004
|
0.83
|
65
|
Genetic variation of SCNN1A influences lung diffusing capacity in cystic fibrosis.
|
Med Sci Sports Exerc
|
2012
|
0.82
|
66
|
Relation of early childhood growth and wheezing phenotypes to adult lung function.
|
Pediatr Pulmonol
|
2011
|
0.79
|
67
|
Relation of beta2-adrenoceptor polymorphisms at codons 16 and 27 to persistence of asthma symptoms after the onset of puberty.
|
Chest
|
2005
|
0.78
|
68
|
The outcomes of sickle cell disease in adulthood are clear, but the origins and progression of sickle cell anemia-induced problems in the heart and lung in childhood are not.
|
J Pediatr
|
2006
|
0.78
|
69
|
Clinical use of tobramycin inhalation solution (TOBI®) shows sustained improvement in FEV1 in cystic fibrosis.
|
Pediatr Pulmonol
|
2013
|
0.77
|
70
|
Predictors of specific airway resistance during childhood.
|
Am J Respir Crit Care Med
|
2014
|
0.75
|
71
|
Influence of genetic variation of the β2-adrenergic receptor on lung diffusion in patients with cystic fibrosis.
|
Pulm Pharmacol Ther
|
2011
|
0.75
|
72
|
Liver involvement in the Hispanic population of North America with cystic fibrosis.
|
J Pediatr Gastroenterol Nutr
|
2014
|
0.75
|